Evidence map›Paper›PMID 39996143›Full record

ArticleInfection and drug resistance2025

Genomic Characterization and Antimicrobial Resistance of ESBL-Producing,

Cailin Wang, Hong Zhang, Rongfen Zhao, Clement Kin-Ming Tsui, Shuwen Deng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Extended-Spectrum β-Lactamase-ProducingInfection and drug resistance · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cailin Wang *Medical Research Center, People's Hospital of Suzhou New District, Suzhou, Jiangsu, People's Republic of China.
Hong Zhang *Department of Medical Microbiology, People's Hospital of Suzhou New District, Suzhou, Jiangsu, People's Republic of China.
Rongfen ZhaoDepartment of Medical Microbiology, People's Hospital of Suzhou New District, Suzhou, Jiangsu, People's Republic of China.
Clement Kin-Ming TsuiInfectious Disease Research Laboratory, National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
Shuwen DengMedical Research Center, People's Hospital of Suzhou New District, Suzhou, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The prevalence of third-generation cephalosporin-resistant and extended-spectrum beta-lactamases (ESBL) producing Objective: This study aimed to investigate the molecular epidemiology, and antimicrobial susceptibility of ESBL-producing Methods: Phenotypic ESBL-producing Results: Eighty-six isolates were collected and sequenced, and genomic analysis identified twenty-five different sequence types (STs). The most prevalent STs were ST131 (n=22, 25.6%), ST1193 (n=16, 18.6%), ST38 (n=9, 10.5%) and ST167 (n=6, 7.0%). Conclusion: Our findings highlighted the prevalence of globally circulating ESBL-producing

Indexed as

antimicrobial resistanceEscherichia coliextended spectrum β-lactamasewhole-genome sequencing

Identifiers

PMID39996143
PMCPMC11849422

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.